Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-yi Xu

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Cancer Letters|February 24, 2016
AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathwaysMing-Yi Xu, Rong Chen, Jing-Xia Yu, et al.
Journal of Digestive Diseases|January 28, 2017
MicroRNA profile analysis in the liver fibrotic tissues of chronic hepatitis B patientsRong Chen, Jun Cheng Wu, Ting Liu, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 6, 2023
Vsig4<sup>+</sup> resident single-Kupffer cells improve hepatic inflammation and fibrosis in NASHHui-Yi Li, Seng-Wang Fu, Jun-Cheng Wu, et al.
Frontiers in Bioscience (Landmark Edition)|December 29, 2015
A 6 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis BMing-Yi Xu, Ying Qu, Zhenghong Li, et al.
World Journal of Gastroenterology|September 10, 2019
MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2Jun-Cheng Wu, Rong Chen, Xin Luo, et al.
Annals of Hepatology|February 21, 2012
Serum N-glycomic markers in combination with panels improves the diagnosis of chronic hepatitis BYing Qu, Chun-Fang Gao, Kun Zhou, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2015
FOXP1 and SPINK1 reflect the risk of cirrhosis progression to HCC with HBV infectionFei Li, Ting Liu, Chun-Yang Xiao, et al.
World Journal of Gastroenterology|October 3, 2019
Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-αTing Liu, Xin Luo, Zheng-Hong Li, et al.
Applied Microbiology and Biotechnology|July 4, 2013
Global transcriptome analysis of Escherichia coli exposed to immobilized anthraquinone-2-sulfonate and azo dye under anaerobic conditionsHai-Kun Zhang, Hong Lu, Jing Wang, et al.
Protein & Cell|June 26, 2016
Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cellsYi Feng, Hai-Yan Ying, Ying Qu, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Cancer Letters|February 24, 2016
AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathwaysMing-Yi Xu, Rong Chen, Jing-Xia Yu, et al.
Journal of Digestive Diseases|January 28, 2017
MicroRNA profile analysis in the liver fibrotic tissues of chronic hepatitis B patientsRong Chen, Jun Cheng Wu, Ting Liu, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 6, 2023
Vsig4<sup>+</sup> resident single-Kupffer cells improve hepatic inflammation and fibrosis in NASHHui-Yi Li, Seng-Wang Fu, Jun-Cheng Wu, et al.
Frontiers in Bioscience (Landmark Edition)|December 29, 2015
A 6 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis BMing-Yi Xu, Ying Qu, Zhenghong Li, et al.
World Journal of Gastroenterology|September 10, 2019
MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2Jun-Cheng Wu, Rong Chen, Xin Luo, et al.
Annals of Hepatology|February 21, 2012
Serum N-glycomic markers in combination with panels improves the diagnosis of chronic hepatitis BYing Qu, Chun-Fang Gao, Kun Zhou, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2015
FOXP1 and SPINK1 reflect the risk of cirrhosis progression to HCC with HBV infectionFei Li, Ting Liu, Chun-Yang Xiao, et al.
World Journal of Gastroenterology|October 3, 2019
Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-αTing Liu, Xin Luo, Zheng-Hong Li, et al.
Applied Microbiology and Biotechnology|July 4, 2013
Global transcriptome analysis of Escherichia coli exposed to immobilized anthraquinone-2-sulfonate and azo dye under anaerobic conditionsHai-Kun Zhang, Hong Lu, Jing Wang, et al.
Protein & Cell|June 26, 2016
Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cellsYi Feng, Hai-Yan Ying, Ying Qu, et al.
Pageof 4